Eritoranum

Eritoranum Uses, Dosage, Side Effects, Food Interaction and all others data.

Eritoranum is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

Eritoranum has been shown to down-regulate the intracellular generation of pro-inflammatory cytokines IL-6 and TNF-alpha in human monocytes.

Table Of contents

• Eritoranum
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Eritoranum
Generic	Eritoran
Eritoran Other Names	Eritoran, Eritorán, Éritoran, Eritoranum
Type
Formula	C66H126N2O19P2
Weight	Average: 1313.6562 Monoisotopic: 1312.843002884
Protein binding	Approximately 55%, primarily to high-density lipoproteins.
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in sepsis and septicemia.

How Eritoranum works

Eritoranum is a toll-like receptor 4 inhibitor.

Half Life

50.4 to 62.7 hours

Innovators Monograph

You find simplified version here Eritoranum